Literature DB >> 6509432

Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea.

M Pollard, P H Luckert.   

Abstract

Piroxicam, a non-steroidal anti-inflammatory agent, was administered in the feed to rats which had been inoculated intra-rectally with N-methylnitrosourea (MNU). When examined 5 months later, the piroxicam-treated rats had a significant reduction of intestinal tumors compared to tumor incidences and tumor numbers in rats which were fed drug-free diet. There was no evidence of toxicity associated with the consumption of piroxicam.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509432     DOI: 10.1016/s0304-3835(84)80035-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.

Authors:  G Morgan
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

2.  Chemoprevention of DMH-induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin.

Authors:  Manpreet Kaur Saini; Kim Vaiphei; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2011-10-12       Impact factor: 3.396

Review 3.  Chemoprevention of colon cancer by dietary fatty acids.

Authors:  B S Reddy
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 4.  Aspirin, NSAIDs, and digestive tract cancers.

Authors:  M J Thun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 5.  Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs.

Authors:  B S Reddy; C V Rao
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

Review 6.  Cyclooxygenase, NSAIDs, and colorectal cancer.

Authors:  R N DuBois; W E Smalley
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

Review 7.  Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer.

Authors:  D Turner; H J Berkel
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

8.  Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors.

Authors:  D W Knapp; R C Richardson; G D Bottoms; R Teclaw; T C Chan
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

Authors:  R N DuBois; J Awad; J Morrow; L J Roberts; P R Bishop
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems.

Authors:  Robert E Click
Journal:  Oncol Discov       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.